Discover trends, market shifts, and competitive outlooks for the anthelmintic drugs industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research

What Is the Current and Projected Market Size of the Anthelmintic Drugs Market Through 2034?

The market size of anthelmintic drugs has seen robust growth in the past few years. It is predicted to surge from $3.16 billion in 2024 to $3.34 billion in 2025, with a compound annual growth rate (CAGR) of 5.6%. Factors such as the high incidence of helminth infections, amplified public health pursuits, an uptick in pharmaceutical R&D, elevated awareness and instruction, and economic progression have contributed to the growth witnessed during the historic period.

The market size for anthelmintic drugs is projected to experience robust growth in the upcoming years, reaching a valuation of $4.11 billion by 2029, growing at a compound annual growth rate (CAGR) of 5.3%. The surge in this forecast period can be ascribed to rising instances of parasitic infections worldwide, an increase in the use of anthelmintics for livestock and pets, heightened health awareness and initiatives, and a growth in international travel. Key trends anticipated during this forecast period include a growing demand for combined therapies, an intensified focus on managing drug resistance, an escalating adoption of personalized medicine, the expansion of telemedicine in overseeing treatment, a rise in research on new drug targets, and heightened emphasis on preventive healthcare measures.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=19291&type=smp

What are the Fundamental Drivers and Innovations Shaping the Anthelmintic Drugs Market?

The growth of the anthelmintic drugs market is likely to be fueled by the high incidence of parasitic infections. These infections are diseases resulting from organisms such as protozoa, worms, or ectoparasites, that inhabit another host. Factors such as poor sanitation, contaminated food or water, close proximity to infected people or animals, lack of hygiene, and limited access to clean resources contribute to the spread of parasitic infections. Anthelmintic drugs, which are used to combat infections by parasitic worms, are efficient in identifying and removing these parasites from inside the host. They achieve this by interfering with the parasites’ vital functions, leading to their expulsion or death. For example, data from the Centers for Disease Control and Prevention, a US-based national public health agency, revealed an increase in the number of cyclosporiasis cases in Florida, a condition caused by a microscopic parasite. From 254 cases in 2021, it jumped to 513 in 2022- an increase recorded in July 2023. With this in mind, the high incidence of parasitic infections is driving growth in the anthelmintic drugs market.

How Is the Anthelmintic Drugs Market Segmented?

The anthelmintic drugsmarket covered in this report is segmented –

1) By Drug Class: Benzimidazoles, Macrocyclic lactones, Pyrazinoisoquinolones, Tetrahydropyrimidines, Other Drug Classes

2) By Route Of Administration: Oral, Injectable

3) By Infection Type: Nematode Infections, Cestode Infections, Trematode Infections, Mixed Infections

4) By Distribution Channel: Hospitals And Clinics, Retail Pharmacies, Online Pharmacies, Veterinary Clinics And Supply Stores

5) By Application: Human Anthelmintics, Veterinary Anthelmintics

Subsegments:

1) By Benzimidazoles: Albendazole, Mebendazole, Fenbendazole, Oxfendazole, Thiabendazole

2) By Macrocyclic Lactones: Ivermectin, Moxidectin, Doramectin, Eprinomectin, Milbemycin Oxime

3) By Pyrazinoisoquinolones: Praziquantel, Cysticide

4) By Tetrahydropyrimidines: Pyrantel Pamoate, Pyrantel Tartrate

5) By Other Drug Classes: Imidazothiazoles, Aminoacetonitrile Derivatives, Spiroindoles, Arsenicals

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=19291&type=smp

Which Regions Are Driving the Next Phase of the Anthelmintic Drugs Market Growth?

North America was the largest region in the anthelmintic drugs market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the anthelmintic drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Key Trends Are Shaping the Future of the Anthelmintic Drugs Market?

In the anthelmintic drugs market, major firms are concentrating their efforts on the invention of innovative combination drugs to deliver extensive protection against numerous parasites. These combination anthelmintic drugs are preparations that unite two or more anthelmintic agents to bolster efficacy against parasitic infections in both humans and animals. The principal advantages of these drugs include a broadened activity spectrum, delayed drug resistance development, and the ability to overcome established resistance profiles in parasites. For instance, Zoetis Inc., an American animal health company, achieved FDA approval for a new label indication of Simparica Trio in January 2022. This drug is designed to guard against infections instigated by Borrelia burgdorferi, which causes Lyme disease in dogs. By merging three active components – sarolaner, moxidectin, and pyrantel, Simparica Trio grants unparalleled protection against fleas, ticks, heartworms, roundworms, and hookworms.

View the full report here:

https://www.thebusinessresearchcompany.com/report/anthelmintic-drugs-global-market-report

How Is the Anthelmintic Drugs Market Defined and What Are Its Core Parameters?

Anthelmintic drugs are medications used to treat infections caused by parasitic worms, or helminths. These drugs work by either killing the worms directly or disrupting their ability to reproduce. They are commonly prescribed for conditions such as roundworm, tapeworm, and hookworm infections.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=19291

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model